SEK
EUR
USD
NEUROSCIENCE CAMPAIGN 20% DISCOUNT ON PRIMARY ANTIBODIES!
Cart
0
Products
Antibody Validation
Applications
Protocols
Knowledge Hub
Customer Support
About Us
Cart
0
Search
Show all Products
MolBoolean
PrEST Control Antigens
Primary Antibodies
PrecisA Monoclonals
Triple A Polyclonals
Antibody Validation
Enhanced Validation
Applications
Immunohistochemistry
Immunocytochemistry
Western Blot
ChIP
Atlas Antibodies to Exhibit at Cell Bio 2024 in San Diego, Highlighting Innovative MolBoolean™ Technology
Atlas Antibodies to Showcase Innovation at Society for Neuroscience Annual Meeting 2024 in Chicago
Atlas Antibodies Presents Pan-Cancer Markers and New Product MolBoolean at EACR 2024
Atlas Antibodies Unveils Revolutionary Molecular Tool, MolBoolean™
Atlas Antibodies is going green!
Ingela Hofverberg appointed as CEO of Atlas Antibodies BU
The Human Protein Atlas (HPA) selected as a Global Core Biodata Resource
Atlas Antibodies acquires HistoCyte Laboratories Ltd.
Atlas Antibodies acquires evitria
Atlas Antibodies has new Chair of the Board Åsa Riisberg
Dr. Stefan Schmidt new CEO of evitria
Gavin Wood and Christian Eberle join Atlas Antibodies’ Board of Directors
